This site is intended for healthcare professionals only
LoginRegister
USFDA issues EIR for Cohance Lifesciences Telangana facilitySurprise Inspection of Pharma Firms in Baddi Amid Counterfeit Drug Concerns
Modernas Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales SlumpModerna's Q4 Revenue Falls 66% to USD 966M Amid COVID Vaccine Sales Slump
West Pharmas 2025 Forecast Misses Estimates as Inventory Reductions ContinueWest Pharma's 2025 Forecast Misses Estimates as Inventory Reductions Continue
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanRetinal examination be done at each visit: CDSCO Panel tells Alkem Lab on Semaglutide Injection...
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAZydus' Ambernath API Plant Clears USFDA Inspection with Zero Observations
Investigation Lapses Lead to Acquittal in Hospital Voyeurism CaseCourt Relief: Pharma MD Gets Bail After 22-Month Jail In Tramadol Smuggling Case
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataUS Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates
Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome CaseSetback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case
Roche receives EU CE mark for Contivue for neovascular age-related macular degenerationUSFDA Approves Roche's Evrysdi Tablet for Spinal Muscular Atrophy
NPPA Sets New Retail Price for Cilnidipine, Telmisartan CombinationNPPA Sets New Retail Price for Cilnidipine, Telmisartan Combination
Shilpa Medicare Unit VI Bengaluru facilityShilpa Medicare Gets CDSCO Panel Nod for Novel NAFLD Drug, Advances to Marketing Approval Stage
Natco Pharma sees major leadership exit in RnD, demand & supply, qualityNatco Pharma Q3 Profit Falls 38% to Rs132 Cr Amid Formulation Export Slump
X